A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis

2000533 citationsJournal Articlebronze Open Access

Authors

David A. Stevens · Santa Clara Valley Medical Center

Howard J. Schwartz · University Hospitals of Cleveland

Jeannette Y. Lee · University of Alabama at Birmingham

Bruce L. Moskovitz

Dennis C. Jerome · Long Beach Medical Center

Antonino Catanzaro

David M. Bamberger · University of Missouri–Kansas City

Allison Weinmann

Abstract

For patients with corticosteroid-dependent allergic bronchopulmonary aspergillosis, the addition of itraconazole can lead to improvement in the condition without added toxicity.

Topics & Keywords

Antifungal resistance and susceptibility Asthma and respiratory diseases Respiratory and Cough-Related Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 342, Issue 11, pp. 756-762

DOI: 10.1056/nejm200003163421102

Field-Weighted Citation Impact: 16.56